IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Cambrex Profits Fall on Low Generic API Sales

10:19 AM MDT | August 18, 2008 | Deepti Ramesh

Cambrex (East Rutherford, NJ) posted second-quarter net profits down 19%, to $1.8 million, on sales up by 5%, to $66.2 million. Sales of generic active pharmaceutical ingredients (APIs) fell in the quarter but were partially offset by higher custom manufacturing revenues, including higher revenues from controlled substances, Cambrex says. “New laboratories in our Iowa facility were commissioned during the second quarter to support growing demand for highly potent compounds,” says Steven Klosk, president and CEO. The company says its new API finishing...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa